Y Intercept (Hong Kong) LTD Chimerix Inc Transaction History

Y Intercept (Hong Kong) LTD

  • $1.78 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.1 - $1.54 $103,219 - $144,507
93,836 New
93,836 $113,000
Q4 2022

Feb 14, 2023
BUY
$1.67 - $2.35 $12,349 - $17,378
7,395 Added 73.42%
17,467 $32,000
Q2 2022

Aug 08, 2022
BUY
$1.34 - $5.34 $13,496 - $53,784
10,072 New
10,072 $21,000

Others Institutions Holding CMRX

# of Institutions
81
Shares Held
36.8M
Call Options Held
72.2K
Put Options Held
169K
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email